Previous Article | Next Article ![]()
Journal of Clinical Microbiology, July 1998, p. 1853-1858, Vol. 36, No. 7
Central Laboratory of Bacteriology,
Received 30 October 1997/Returned for modification 30 December
1997/Accepted 17 March 1998
Between August 1994 and September 1996, 28 glycopeptide-resistant
enterococci (GRE) were isolated from 8 infected patients and 11 intestinal carriers hospitalized at the University Hospital of Geneva.
Identification to the species was made by both phenotypic (API 20 STREP
and Rapid ID 32 STREP systems, and Vitek Gram Positive Identification
Card) and genotypic methods using a multiplex PCR assay developed also
for the determination of the genotype of glycopeptide
resistance (vanA, vanB, vanC1, and
vanC2-C3 genes). Fifteen isolates were identified as
Enterococcus faecium, 8 as E. gallinarum, 4 as
E. faecalis, and 1 as E. hirae. All of the phenotypic identification methods failed to differentiate some isolates of E. gallinarum from E. faecium, or
vice versa. Both vanA (n = 18) and
vanB (n = 4) glycopeptide resistance
genotypes were found. For the first time, the vanB
determinant was found in two isolates of E. gallinarum. Two
patients were colonized by two different species containing the
vanA gene and one by two different species containing the
vanB gene. All vanA isolates were
highly resistant to both vancomycin and teicoplanin except for
three isolates which were susceptible to teicoplanin. Molecular typing
by pulsed-field gel electrophoresis showed identical or similar
patterns among E. faecium isolates with the
vanA gene in five patients for whom the epidemiological
link could not be always elucidated. This study emphasizes the
necessity of utilizing both phenotypic and genotypic methods to
characterize GRE.
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Characterization of Glycopeptide-Resistant
Enterococci from a Swiss Hospital
*
Corresponding author. Mailing address: Central
Laboratory of Bacteriology, University Hospital, 25 rue
Micheli-du-Crest, 1211 Geneva 4, Switzerland. Phone: (41) (22) 372 73 09. Fax: (41) (22) 372 73 04. E-mail:
Nadia.Liassine{at}hcuge.ch.
Journal of Clinical Microbiology, July 1998, p. 1853-1858, Vol. 36, No. 7
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»